new glp 1 medication FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Popular GLP-1 medications may have

GHRH-pathway peptides like Sermorelin work upstream of the pituitary, preserving your own production capacity and creating a more physiologic pulse pattern

it is not known if they will cause thyroid tumors or cancer in humans

It is not supplied for human consumption, veterinary use, cosmetic use, diagnostic use, medical use, therapeutic use, supplementation, wellness use, performance enhancement, personal use, or administration to humans or animals

Kidney protection: the FLOW trial The FLOW trial studied semaglutide in patients with type 2 diabetes and chronic kidney disease

It is also important to remember that sermorelin is contraindicated for anyone with an active cancer, as growth hormone can influence cell growth